Literature DB >> 12952810

Paroxetine (Paxil, Seroxat): increased risk of suicide in pediatric patients.

Eric Wooltorton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12952810      PMCID： PMC183305     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  Focus on paroxetine.

Authors:  Ben Green
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

Review 2.  Depression in children and adolescents.

Authors:  Philip Hazell
Journal:  Am Fam Physician       Date:  2003-02-01       Impact factor: 3.292

Review 3.  Medication treatment for depression in children and adolescents.

Authors:  Neal D Ryan
Journal:  CNS Spectr       Date:  2003-04       Impact factor: 3.790

Review 4.  Diagnosis and management of depression in primary care: a clinical update and review.

Authors:  Ronald A Remick
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

Review 5.  Depression in children and adolescents.

Authors:  S E Son; J T Kirchner
Journal:  Am Fam Physician       Date:  2000-11-15       Impact factor: 3.292
  5 in total
  6 in total

1.  Facing the evidence: antidepressant treatment in children and adolescents.

Authors:  E Jane Garland
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

Review 2.  Social anxiety disorder : current treatment recommendations.

Authors:  Jacqueline E Muller; Liezl Koen; Soraya Seedat; Dan J Stein
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.

Authors:  Darren Lam; Daniel A Gorman; Scott Patten; Tamara Pringsheim
Journal:  Paediatr Drugs       Date:  2013-08       Impact factor: 3.022

Review 4.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

Review 5.  A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials.

Authors:  Margaret Coates; Marina Spanos; Pooja Parmar; Tara Chandrasekhar; Linmarie Sikich
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

6.  Clinical Trials Registry - India: An overview and new developments.

Authors:  M Vishnu Vardhana Rao; Mohua Maulik; Jyotsna Gupta; Yashmin Panchal; Atul Juneja; Tulsi Adhikari; Arvind Pandey
Journal:  Indian J Pharmacol       Date:  2018 Jul-Aug       Impact factor: 1.200
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.